UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000007347
Receipt number R000008660
Scientific Title Feasibility study of dedicated breastPET(db PET) for evaluating therapeutic effects of primary systemic therapy (PST).
Date of disclosure of the study information 2012/03/01
Last modified on 2012/12/25 19:20:01

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

Feasibility study of dedicated breastPET(db PET) for evaluating therapeutic effects of primary systemic therapy (PST).

Acronym

Feasibility study of dbPET

Scientific Title

Feasibility study of dedicated breastPET(db PET) for evaluating therapeutic effects of primary systemic therapy (PST).

Scientific Title:Acronym

Feasibility study of dbPET

Region

Japan


Condition

Condition

Breast cancer

Classification by specialty

Breast surgery

Classification by malignancy

Malignancy

Genomic information

NO


Objectives

Narrative objectives1

Evaluating the images obtained by dbPET, not whole body PET, in PST

Basic objectives2

Efficacy

Basic objectives -Others


Trial characteristics_1

Confirmatory

Trial characteristics_2

Pragmatic

Developmental phase

Not applicable


Assessment

Primary outcomes

FDG PET images on dbPET scan after the first cycle of PST.

Key secondary outcomes

Comparison between db PET and MRI or pathologic findings of resected specimen


Base

Study type

Interventional


Study design

Basic design

Single arm

Randomization

Non-randomized

Randomization unit


Blinding

Open -no one is blinded

Control

Uncontrolled

Stratification


Dynamic allocation


Institution consideration


Blocking


Concealment



Intervention

No. of arms

1

Purpose of intervention

Diagnosis

Type of intervention

Device,equipment

Interventions/Control_1

db PET

Interventions/Control_2


Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

20 years-old <=

Age-upper limit


Not applicable

Gender

Female

Key inclusion criteria

1. Female patients with primary breast cancer diagnosed by palpation, imagings and cytology, with T stage >=T1and M0.
2.The patinets should be scheduled to receive PST.
3.Female patients who can agree to participate in this study of their own will, and aged 20 years and older at the time of informed consent.

Key exclusion criteria

1. Patients with sever impairement in communications.
2. Patients with very poor general conditions (such as abnormal vital signs).
3. Patients who are pregnancy or suspicion of pregnancy.
4. Patients who are judged ineligible to enroll into this clinical study due to any reasons by the doctor.

Target sample size

40


Research contact person

Name of lead principal investigator

1st name
Middle name
Last name Masakazu Toi

Organization

Graduate School of Medicine Kyoto University

Division name

Breast Surgery

Zip code


Address

54 Shogoin Kawara-cho, Sakyo-ku, Kyoto, Japan

TEL

075-751-3660

Email



Public contact

Name of contact person

1st name
Middle name
Last name Tomoharu Sugie

Organization

Graduate School of Medicine Kyoto University

Division name

Breast Surgery

Zip code


Address

54 Shogoin Kawara-cho, Sakyo-ku, Kyoto, Japan

TEL

075-751-3660

Homepage URL


Email

sugie@kuhp.kyoto-u.ac.jp


Sponsor or person

Institute

Graduate School of Medicine Kyoto University

Institute

Department

Personal name



Funding Source

Organization

Ministry of Education, Culture, Sports, Science and Technology

Organization

Division

Category of Funding Organization

Nationality of Funding Organization

JAPAN


Other related organizations

Co-sponsor

Shimazu Co.

Name of secondary funder(s)

Shimazu Co.


IRB Contact (For public release)

Organization


Address


Tel


Email



Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions



Other administrative information

Date of disclosure of the study information

2012 Year 03 Month 01 Day


Related information

URL releasing protocol


Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled


Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Open public recruiting

Date of protocol fixation

2012 Year 02 Month 28 Day

Date of IRB


Anticipated trial start date

2012 Year 04 Month 05 Day

Last follow-up date

2014 Year 08 Month 31 Day

Date of closure to data entry


Date trial data considered complete


Date analysis concluded



Other

Other related information



Management information

Registered date

2012 Year 02 Month 21 Day

Last modified on

2012 Year 12 Month 25 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000008660


Research Plan
Registered date File name

Research case data specifications
Registered date File name

Research case data
Registered date File name